These data further validated the correlations between ATAD2 and TGF-β1 and epithelial-mesenchymal transition as well as the correlation between C/EBPβ and TGF-β1 in ESCC patients. The gene discussed is ATAD2; the disease is esophageal squamous cell carcinoma.